Katrin Roth - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Katrin Roth

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Gut|June 4, 2024

DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancerAnna Brichkina, Miriam Ems, Roman Suezov, et al.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2015

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 studyOsama Sabri, Marwan N Sabbagh, John Seibyl, et al.

Targeted Oncology|December 16, 2016

Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancerJean-Luc Van Laethem, Hanno Riess, Jacek Jassem, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular CarcinomaHo Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.

Cell Death and Differentiation|April 23, 2022

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Gut|June 4, 2024

DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancerAnna Brichkina, Miriam Ems, Roman Suezov, et al.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2015

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 studyOsama Sabri, Marwan N Sabbagh, John Seibyl, et al.

Targeted Oncology|December 16, 2016

Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancerJean-Luc Van Laethem, Hanno Riess, Jacek Jassem, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular CarcinomaHo Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.

Cell Death and Differentiation|April 23, 2022

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivityDennis Das Gupta, Christoph Paul, Nadine Samel, et al.

Pageof 5